Hans LOIBNER,Manfred SCHUSTER,Evelyne JANZEK-HAWLAT,Susanne WIEDERKUM,Bernhard PEBALL,Stefan STRANNER,Oliver MUTSCHLECHNER,Franz GROISS,Ruth LADENSTEIN,Holger LODE
申请号:
US15700538
公开号:
US20180134801A1
申请日:
2017.09.11
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.